MIRA INFORM REPORT
|
Report Date : |
31.07.2008 |
IDENTIFICATION
DETAILS
|
Name : |
LONZA AG |
|
|
|
|
Registered Office : |
Lonzastrasse, CH-3930
Visp/VS |
|
|
|
|
Country : |
Switzerland |
|
|
|
|
Financials (as on) : |
31.12.2007 |
|
|
|
|
Date of Incorporation : |
09.12.1897 |
|
|
|
|
Legal Form : |
Joint Stock
Company |
|
|
|
|
Line of Business : |
Development
and Production of Organic Fine Chemicals |
RATING &
COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
EUR 2.500.000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
Name & address
Lonza AG
Lonzastrasse
CH-3930 Visp/VS
Tel.: 0041/27/9485111
Fax.: 0041/27/9475111
Email: contact.vis@lonza.com
|
Overall
Assessment: |
|
|
|
|
Business relations may be
established. |
|
|
Detail
Assessment: |
Payments: |
|
|
|
Prompt and correct |
|
|
|
Individual
Credit Limit*: |
EUR 2.500.000,-- |
Name
Lonza AG
Line
of Business
Spezialitaetenchemie
Legal
domicile
Lonzastrasse
3930 Visp/VS
Switzerland
Telephone: 027 9485111
Fax: 027 9475111
Homepage: www.lonza.com
E-Mail: contact.visp@lonza.com
All amounts in this report
are given in Swiss Francs (CHF) unless otherwise stated.
GENERAL COMPANY DATA
OFFICIAL DATA:
Legal form: Joint
stock company
First Publication: 09-12-1897
Last Publication: 18-06-2008
Created by: The
company was newly established.
Share capital:
60.000.000
Paid up:
60.000.000
Divided into: 240.000
Bearer shares of 250
History:
28-11-2002 60.000.000 Capital
decrease
06-10-1998 62.500.000 Capital
decrease
29-04-1994 125.000.000 Capital
increase
120.000.000 Previous capital
Shareholders:
Direct Parent com.: Lonza Group AG, 4052 Basel/BS, Switzerland/CH with
share of 100.
Company Management: Stefan Borgas
Registered name 26-01-1962
Lonza AG
06-08-1928 Lonza, Elektrizitaetswerke und
chemische Fabriken AG
Previous
Elektrizitaetswerk Lonza
Registered domicile 20-12-1999, 3930 Visp/VS
Previous, 3945
Gampel/VS
ESTABLISHMENT DETAILS
Administration: Muenchensteinerstrasse 38,
Postfach 4002 Basel,
4052 Basel
Telephone: 061
3168111, Fax: 061 3169111
ACTIVITY:
Line of business: Development
and production of organic fine chemicals
Sector:
Manufacture/Wholesale
Activity:
The scope of business encompasses research, manufacture and marketing of
chemicals, such as organic fine chemicals for pharmaceuticals, plant
protectors, dystuffs, plastics etc.
Products:
Markets:
- Healthcare and plant protectants
- Nutrition
- Hygiene
- Polymers
- Other industrial applications
Locations: Location of
branches: Basel.
The branch in Basel is the group's administrative center at
Muenchensteinstrasse 38.
Trading area:
International
Import/Export: The company
is active in Import and Export.
EMPLOYEES:
Number of employees: 2.900
Personnel of the Lonza Group as of 31.12.:
Total Average Switzerland
----- ------- -----------
2007: 7'711 6'929 2'886
2006: 6'146 6'065
2'769
2005: 5'984 5'826 2'580
2004: 5'668 5'664
2'509
2003: 5'659 5'938 2'550
PAYMENT AND FINANCIAL DATA
PAYMENT EXPERIENCES:
Legal actions: Position per 30-11-2006.
Report from 30-11-2006, in 3930
Visp.
2004 2005 2006
No. Amount
No. Amount No.
Amount
Betreibungen None 0 1 166.000 1 166.000
Rechtsvorschl. 1 166.000 1 166.000
A current check of the legal actions requires a document of
justficiation with a legitimate signature.
The mode of payment and business conduct are regarded as prompt and
correct.
FINANCIAL DATA:
Financial position: The
financial situation is considered solid.
Key figures (in CHF):
Consolidated key figures (in CHF 1.000.000):
Lonza
Group
31.12.2007 31.12.2006
31.12.2005 31.12.2004
12 Months 12
Months 12 Months 12 Months
Sales 2'870.0 2'914.0 2'521.0 2'182.0
Operating
Profit/Loss 408.0 344.0 297.0 211.0
Cost of
employees 857.0 704.0 599.0 549.0
Depreciation 224.0 198.0 184.0 163.0
Profit/Loss 301.0 222.0 188.0 138.0
Cash-Flow 644.0 425.0 413.0 178.0
Investments 609.0 371.0 272.0 249.0
Research/Development 89.0 76.0
63.0 72.0
Shareholder
funds 1'808.0 1'607.0 1'490.0 1'285.0
Balance
sheet total 4'951.0 3'912.0 4'331.0 3'341.0
Inssured
value of 4'979.0 4'202.0 4'785.0 4'607.0
assets
The group published the followed half-yearly figures (in million CHF):
as of 30.06.2007: as of 30.06.2008:
Turnover: 1'374 1'463
Operating
Income: 204 235
Profit/Loss: 146 267
Cash
Flow: 186 106
Equity
Capital: 1'789 1'841
Total
Assets: 4'932 5'148
Banker(-s): Credit Suisse (CS),
UBS Ltd,
Auditors: KPMG AG, Basel
Real estate property: The
company owns an extensive number of
properties.
The group owns numerous properties in Switzerland and abroad. The
acquisition value of the land, buildings and structures as well as the
insurance value of the buildings and structures amount to (in CHF, as of
31.12.):
Acquisition cost Book value Insurance value
---------------- ---------- ---------------
2007 1.261.000.000.-- 760.000.000.--
1.582.000.000.--
2006 1.179.000.000.-- 711.000.000.--
948.000.000.--
2005 1.091.000.000.-- 625.000.000.--
899.000.000.--
2004 1.018.000.000.-- 575.000.000.--
885.000.000.--
2003 893.000.000.-- 457.000.000.--
829.000.000.--
Fiscal taxation: No
information is available due to the local tax
authority regulation.
COMPANY
AND PERSON RELATIONS
COMPANY CONNECTIONS:
Direct Parent com.: Lonza Group
AG, 4052 Basel/BS, Switzerland/CH with
a share of 100.
The shares of Lonza Group are listed on the SWX Swiss Exchange and
traded on virt-x, an electronic trading system based in London.
Major shareholders at 31.12.2007:
- The Capital Group Companies, Inc. Los Angeles (USA)
(5.24% of voting rights)
- Franklin Templeton Companies, LLC, Fort Lauderdale (USA)
(9.68% of voting rights)
- Lonza Group Ltd, Basel (Switzerland), and Lonza Finance
Limited, St. Helier, Jersey
(GB)
(5.71% of voting rights)
- EMS-Chemie Holding AG, Reichenau (Switzerland)
(4.64% of voting rights)
- Marsico Capital Management, LLC, Denver (USA)
4.76% of voting rights
- Manning & Napier Advisores, Inc., Faiport (USA)
(3.81% of voting rights)
- Threadneedle Asset Management Holding Ltd, London (GB)
(3.10%)
Lonza is one of Europe's medium-sized speciality chemicals companies and
is recognized as a leading supplier to the Life-Science Industries.
Investments: In the group are
approximately 39 companies, of
which 5 are
in Switzerland and 34 abroad.
Direct Investments:
Lonza
Braine SA, Braine l'Alleud, Belgium/BE.
Lonza Hongkong Ltd., Hongkong,
China/CN.
The said number of investment holdings represents the group's principal
subsidiaries and affiliates.
BOARD OF DIRECTORS:
Stefan
Borgas, from Germany, in
Muttenz/BL/Switzerland,
President,
collective signature.
Dr. Toralf
Haag, from Germany, in
Biel-Benken/BL/Switzerland,
Member, collective
signature.
Dr. Lukas Utiger, from
Baar, Luzern, in
Gipf-Oberfrick/AG/Switzerland,
Member, collective signature.
MANAGEMENT:
Dr. Uwe
Boehlke, from Germany, in
Biel/Bienne/BE/Switzerland,
Director,
collective signature.
Dr. Walter Eschenmoser, from Zuerich, in
Bottmingen/BL/Switzerland,
Director,
collective signature.
Dr. Stephan
Kutzer, from Germany, in Greenland
NH,/America,
Director,
collective signature.
Johan P.
Manuel, from Netherlands, in
Allschwil/BL/Switzerland,
Director, collective signature.
Raoul
Bayard, from Varen, in Glis/VS/Switzerland,
Asst.
Director, collective signature.
Dr. Martin
Clausen, from Ernen, in
Brig-Glis/VS/Switzerland,
Asst. Director,
collective signature.
Walter Fux,
from St. Niklaus VS, in
Sissach/BL/Switzerland,
Asst.
Director, collective signature.
Klaus Kalbermatter, from Niedergesteln, Hohtenn,
in
Brig-Glis/VS/Switzerland,
Asst. Director, collective
signature.
Dr. Hans Peter
Pfirter, from Muttenz, Basel, in
Muttenz/BL/Switzerland,
Asst.
Director, collective signature.
Dr. Felix
Previdoli, from Brig-Glis, in
Brig-Glis/VS/Switzerland,
Asst. Director,
collective signature.
Roman
Quinter, from Trun, in
Zeiningen/AG/Switzerland,
Asst.
Director, collective signature.
Stefan Stoffel, from Visperterminen, in
Unterbaech/VS/Switzerland,
Asst. Director,
collective signature.
Dr. Raymond
Vouillamoz, from Riddes, in
Granois/VS/Switzerland,
Asst.
Director, collective signature.
PERSONNEL INFORMATION:
The top-level members of the management enjoy a good reputation in
business affairs.
FURTHER MANDATES:
Stefan Borgas:
- Lonza Group AG, Basel
- Lonza Bioproducts AG, Basel
COMMENTS:
Your request was on Muenchensteinerstrasse 38 in Basel:
------------------------------------------------------
At this address is the legal seat of the parent company Lonza Group AG.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 42.49 |
|
UK Pound |
1 |
Rs. 84.21 |
|
Euro |
1 |
Rs. 66.33 |
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)